Select to view the solutions available in your location.
Track orders, get results, manage personal information, and more.
Order tests, track orders, get results, and more.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
How one revolutionary test could change the health of millions.
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
Several Exact Sciences initiatives address disparities in cancer outcomes among U.S. Latinos.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
Last Friday, Exact Sciences Chairman and CEO Kevin Conroy appeared on CNBC's Mad Money to discuss Cologuard, Exact Sciences' FDA-approved noninvasive stool DNA screening test for colorectal cancer (available by prescription only).
You can watch a clip of Conroy's appearance below. For other investor content, view our investor site or investor blog.